| Income Statement | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Total expenses | 55,694,053 | 54,511,116 | 53,065,728 | 51,942,496 |
| Operating income (loss) | -906,772 | 2,542,924 | -4,686,112 | -6,305,566 |
| Interest expense, net | 663,027 | 626,275 | 558,597 | 531,468 |
| Income (loss) from continuing operations before income taxes, noncontrolling interest | - | - | -5,244,709 | - |
| Income tax expense (benefit) | - | - | 232,523 | - |
| Net (loss) income | -1,569,799 | 1,916,649 | -5,477,232 | -6,837,034 |
| Net income attributable to non-controlling interest | 505,075 | 531,845 | -345,767 | 38,606 |
| Net loss attributable to lifemd, inc | -2,074,874 | 1,384,804 | -5,131,465 | -6,875,640 |
| Preferred stock dividends | 776,562 | 776,563 | 776,563 | 776,562 |
| Net loss attributable to lifemd, inc. common stockholders | -2,851,436 | 608,241 | -5,908,028 | -7,652,202 |
| Basic | 44,401,531 | 43,135,778 | 42,020,965 | 41,296,042 |
| Diluted | 44,401,531 | 45,580,311 | 42,020,965 | 41,296,042 |
LifeMD, Inc. (LFMD)
LifeMD, Inc. (LFMD)